Evidence map›Paper›PMID 31936872›Full record

ArticleMolecules (Basel, Switzerland)2020

Antimicrobial Activity of Protein Fraction from

Aleksandra Bocian, Ewa Ciszkowicz, Konrad K Hus, Justyna Buczkowicz, Katarzyna Lecka-Szlachta, Monika Pietrowska, Vladimír Petrilla, Monika Petrillova, Ľubomír Legáth, Jaroslav Legáth

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Bioactive Properties of Selected EuropeanInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. AMPEC4:Molecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Inhibition of bacterial biofilms by the snake venom proteome.Biotechnology reports (Amsterdam, Netherlands) · 2023
    Article
  9. Article
  10. Antibacterial Activity of Venom from the Puff Adder (International journal of microbiology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effects of 3FTx Protein Fraction fromMolecules (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Aleksandra BocianFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Ewa CiszkowiczFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Konrad K HusFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Justyna BuczkowiczFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Katarzyna Lecka-SzlachtaFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Monika PietrowskaMaria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-100 Gliwice, Poland.
Vladimír PetrillaDepartment of Anatomy, Histology and Physiology, University of Veterinary Medicine and Pharmacy, Komenského 73, 041 81 Kosice, Slovakia.
Monika PetrillovaDepartment of General Education Subjects, University of Veterinary Medicine and Pharmacy, Komenského 73, 041 81 Kosice, Slovakia.
Ľubomír LegáthDepartment of Occupational Medicine and Clinical Toxicology, Pavol Jozef Šafárik University Faculty of Medicine and Louis Pasteur University Hospital, Rastislavova 43, 041 90 Košice, Slovakia.
Jaroslav LegáthFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Rzeszów University of Technology · PLUniversity of Veterinary Medicine in Košice · SKThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Pavol Jozef Šafárik · SK

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-17-0017Narodowe Centrum Nauki 2018/02/X/NZ6/00840
6 · The paper itself

Abstract

One of the key problems of modern infectious disease medicine is the growing number of drug-resistant and multi-drug-resistant bacterial strains. For this reason, many studies are devoted to the search for highly active antimicrobial substances that could be used in therapy against bacterial infections. As it turns out, snake venoms are a rich source of proteins that exert a strong antibacterial effect, and therefore they have become an interesting research material. We analyzed

Indexed as

Anti-Bacterial AgentsElapid VenomsNajaAnimalsBiofilmsStaphylococcus epidermidisAnti-Bacterial AgentsElapid Venomsantimicrobial propertiesbiofilmMICNaja asheivenom proteins

Identifiers

PMID31936872
PMCPMC7024148
OpenAlexW2998817375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.